[Comment] Polymyxins resistance among Gram-negative pathogens in India

alkiviadis.1961 shared this article with you from Inoreader [Comment] Polymyxins resistance among Gram-negative pathogens in India Via The Lancet Infectious Diseases The sharp increase in carbapenem resistance in Gram-negative pathogens during the past decade led to a resurgence in the use of polymyxin antibiotics. Despite treatment-associated acute kidney injury and varying clinical outcomes, both colistin (polymyxin E) and polymyxin B have emerged as key therapies in the management of carbapenem-resistant Gram-negative infections. Use of these therapies is particularly frequent in low-income and middle-income countries where access to novel antibiotics that are active against carbapenem-resistant Gram-negative bacteria, such as ceftazidime plus avibactam and ceftolozane plus tazobactam, is restricted. View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.